Content about PSE

May 31, 2013
Fruth decides to only carry diversion-resistant PSE product Nexafed behind the counter

Fruth Pharmacy announced their commitment to replace medications containing pseudoephedrine, a nonprescription decongestant that can be used in the illicit manufacture of methamphetamine, with Nexafed, a PSE product formulated with Impede technology that disrupts the extraction and conversion of PSE to meth.

POINT PLEASANT, W.Va. — Fruth Pharmacy on Friday announced their commitment to replace medications containing pseudoephedrine, a nonprescription decongestant that can be used in the illicit manufacture of methamphetamine, with Nexafed, a PSE product formulated with Impede technology that disrupts the extraction and conversion of PSE to meth.

Currently, medications with 30 mg of PSE will be replaced with other mg amounts being replaced as soon as possible, the 27-store chain stated.

April 21, 2013
Meth-resistant PSE

Westport Pharmaceuticals has been showcasing its Zephrex-D "meth-resistant" pseudoephedrine-based decongestant that is now available in retail stores throughout Missouri. It's a hot product as much for the sales generated, as for the sales not lost.

ST. LOUIS — Westport Pharmaceuticals has been showcasing its Zephrex-D "meth-resistant" pseudoephedrine-based decongestant that is now available in retail stores throughout Missouri. It's a hot product as much for the sales generated, as for the sales not lost.

February 15, 2013
GAO issues report on the impact PSE sales restrictions have on meth labs

According to a report filed to Congress by the Government Accountability Office on Wednesday, the seizures of methamphetamine-producing labs declined following state and federal sales restrictions on pseudoephedrine.

WASHINGTON — According to a report filed to Congress by the Government Accountability Office on Wednesday, the seizures of methamphetamine-producing labs declined following state and federal sales restrictions on pseudoephedrine. And while electronic tracking systems help enforce PSE sales limits, those efforts have not reduced meth lab incidents and have limitations related to smurfing, the GAO added. 

November 15, 2012
ReportersNotebook — Over the Counter, 11/19/12

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

SUPPLIER NEWS — Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine. Couched as the “next generation pseudoephedrine product,” Nexafed is a 30 mg PSE hydrochloride tablet that utilizes Acura’s trademarked Impede technology. 


November 8, 2012
Acura Pharmaceuticals moves forward with plans to launch diversion-hindering PSE product

Acura Pharmaceuticals on Wednesday shared with analysts details on its launch strategy of Nexafed, a pseudoephedrine formulated such that in inhibits the diversion to methamphetamnine.

PALATINE, Ill. — Acura Pharmaceuticals on Wednesday shared with analysts details on its launch strategy of Nexafed, a pseudoephedrine formulated such that it inhibits the diversion to methamphetamnine. 

October 29, 2012
Acura Pharmaceuticals introduces PSE product that will be less attractive to 'meth cooks'

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

PALATINE, Ill. — Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine. Couched as the "next generation pseudoephedrine product," Nexafed is a 30-mg PSE hydrochloride tablet that utilizes Acura's trademarked Impede technology. 

March 18, 2011
PSE's Rx-only switch in Arkansas opens a new can of worms

The latest Arkansas proposition to control PSE sales may deliver the biggest blow to the over-the-counter accessibility argument, as it restricts sales to Arkansas residents who have a state-issued picture ID and who don’t look like they might be meth addicts. It also is no more fair or effective to have pharmacists decide who looks like a meth addict and who doesn't. Worse, the bill includes a provision that would allow the Arkansas Board of Pharmacy to color any OTC medicine with the same brush as PSE.

WHAT IT MEANS AND WHY IT’S IMPORTANT — The latest Arkansas proposition to control PSE sales may deliver the biggest blow to the over-the-counter accessibility argument, as it restricts sales to Arkansas residents who have a state-issued picture ID and who don’t look like they might be meth addicts. It also is no more fair or effective to have pharmacists decide who looks like a meth addict and who doesn't. Worse, the bill includes a provision that would allow the Arkansas Board of Pharmacy to color any OTC medicine with the same brush as PSE.

December 3, 2010
Moving PSE to Rx-only in Mo. lacks fiscal sense

The forward-looking vision employed by Gov. Jay Nixon in exploring “next steps” in fighting methamphetamine abuse before even the last step has been put into place and enacted is, in a matter of speaking, extremely short-sighted. It doesn’t even make fiscal sense, because the National Precursor Log Exchange will do more to curb many of the costs associated with fighting meth addicts without conversely increasing the costs associated with fighting a cold. And truth be told, there are probably a lot more stuffy heads in Missouri than there are meth addicts.

WHAT IT MEANS AND WHY IT'S IMPORTANT — The forward-looking vision employed by Gov. Jay Nixon in exploring “next steps” in fighting methamphetamine abuse before even the last step has been put into place and enacted is, in a matter of speaking, extremely short-sighted. It doesn’t even make fiscal sense, because the National Precursor Log Exchange will do more to curb many of the costs associated with fighting meth addicts without conversely increasing the costs associated with fighting a cold.

May 16, 2010
Congress heats up e-tracking debate to fight meth cooks

Electronic tracking or prescription-only? That’s the question that vexed Congressional leaders last month as they...

October 18, 2009
Report: Union, Mo., passes new PSE legislation

There is a big danger here, and it’s a danger that has less to do...

NEW YORK There is a big danger here, and it’s a danger that has less to do with the neighborhood meth addict in search of pseudoephedrine, and more to do with appropriate access to medicines and who gets to be the gatekeeper to that access. Because not only will a prescription-only PSE restrict consumer access to a legitimate nonprescription cough-cold ingredient, but if successfully mandated by the local government, it also has the potential to limit legitimate access to just about any cost-saving OTC medicine and for just about any reason.